CHLA Clinical Research Studies

Having volunteers participate in research studies and clinical trials is critical to our research efforts. Thousands of children and families are involved in our patient-centered studies every year. Many of the treatments used today are based on the results of past research studies and clinical trials conducted with our patients. Our scientific and clinical experts take the best ideas from the laboratory -- to the patient -- in the form of promising new treatments.

By searching our study directory, you may identify research that could impact the life of your child or of another child you know. Because the number of available research studies and clinical trials for children nationwide is small, every participant makes a significant contribution.

In addition to enrolling children with certain diseases in order to study treatments and prevention of those diseases, we also need to study healthy children. Ask your child’s doctor about volunteer study options that may be suitable for your child.

Please contact the study staff listed in your search results for more information.

Search by Keyword:    

Back to the full listing

Study Details - ID: CHLA-19-00013
Health/Science/Disease Category:
Prader-Willi-Syndrome (PWS)
Purpose of Research:
This research is being done to test the safety and effectiveness of intranasal carbetocin to treat Prader Willi Syndrome
Short Name:
Full Title of Study:
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) with Long Term Follow-Up: CARE-PWS
Phase/Type of Study:
Phase 3
7 to 18 years of age. Genetically confirmed PWS
Time Commitment/Requirements:
Participation will last up to 8 weeks, with 10 study visits and a long term follow up of 56 weeks, totaling 66 weeks.
Primary Investigator:
Alaina Vidmar, MD
Coordinator Contact Name:
Jocelyn Martinez
Phone Number:
323-361-7971 or 323-361-6446
Clinical Trials .Gov Identifier: